Omya will showcase its new excipient, Omyapharma, during CPhI Worldwide 2016.
During CPhI 2016 in Barcelona, Spain, Omya, the global producer of calcium carbonate, will showcase Omyapharm, its newly developed pharmaceutical excipient (booth 4F77SSP). The functionalized calcium carbonate can be used in multiple applications, such as orally dispersible granules (ODGs) or tablets (ODTs) that offer high mechanical strength.
Omyapharm is manufactured from high purity natural calcium carbonate using a surface recrystallization process. The external lamellae of the particles provide interlocking contact points. After drug loading, Omyapharm orally dispersible granules can be directly compressed into ODTs, which keep and preserve the active substances and disintegrate in less than 10 seconds. The high porosity of ODTs formulated with Omyapharm makes disintegration rapid and even. With their high mechanical strength, tablets formulated with Omyapharm as an excipient can be filled in regular bottles and blisters, which significantly reduces the cost of packaging.